Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study

Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F; NormoCAT Study Investigators

(2010), Aliment Pharmacol Ther, 31(8), 834-45

Magnetic resonance colonography for colorectal cancer screening in patients with Lynch syndrome gene mutation

Lim EJ, Leung C, Pitman A, Stella DL, Brown G, Slattery M, Marion K, Macrae F

(2010), Fam Cancer, 9(4), 555-61

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, Botwick W, Shreeniwas R

(2010), Clin Immunol, 134(3), 289-95

The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all

Melmed GY, Spiegel BM, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Siegel CA

(2010), Clin Gastroenterol Hepatol, 8(8), 655-9

IBD: Switching metabolism-can two drugs be better than one?

Sparrow M

(2010), Nat Rev Gastroenterol Hepatol, 7(8), 420-2

Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia

Connell W, Andrews JM, Brown S, Sparrow M

(2010), Intern Med J, 40(2), 139-49

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Gane EJ, Roberts SK, Stedman CA, Angus PW, Ritchie B, Elston R, Ipe D, Morcos PN, Baher L, Najera I, Chu T, Lopatin U, Berrey MM, Bradford W, Laughlin M, Shulman NS, Smith PF

(2010), Lancet, 376(9751), 1467-75

A Phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

Gowans EJ, Roberts S, Jones K, Dinatale I, Latour PA, Chua B, Eriksson EM, Chin R, Li S, Wall DM, Sparrow RL, Moloney J, Loudovaris M, Ffrench R, Prince HM, Hart D, Zeng W, Torresi J, Brown LE, Jackson DC

(2010), J Hepatol, 53(4), 599-607

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing

Cheng WS, Roberts SK, McCaughan G, Sievert W, Weltman M, Crawford D, Rawlinson W, Marks PS, Thommes J, Rizkalla B, Yoshihara M, Dore GJ; CHARIOT Study Group

(2010), J Hepatol, 53(4), 616-23

Azathioprine and allopurinol: a two-edged interaction

Gearry RB, Day AS, Barclay ML, Leong RW, Sparrow MP

(2010), J Gastroenterol Hepatol, 25(4), 653-5

Viral response guided therapy for hepatitis C in the approaching era of direct acting anti-viral agents

Berzsenyi MD, Roberts SK

(2010), J Gastroenterol Hepatol, 25(4), 655-6

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P

(2010), Hepatology, 51(2), 388-97

Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models

Limmathurotsakul D, Jamsen K, Arayawichanont A, Simpson JA, White LJ, Lee SJ, Wuthiekanun V, Chantratita N, Cheng A, Day NP, Verzilli C, Peacock SJ

(2010), PLoS One, 5(8), e12485

Predictors of pain severity 3 months after serious injury

Holmes A, Williamson O, Hogg M, Arnold C, Prosser A, Clements J, Konstantatos A, O'Donnell M

(2010), Pain Med, 11(7), 990-1000

Predictors of pain 12 months after serious injury

Holmes A, Williamson O, Hogg M, Arnold C, Prosser A, Clements J, Konstantatos A, O'Donnell M

(2010), Pain Med, 11(11), 1599-611

Measuring the success of an objective structured clinical examination for dietetic students

Hawker JA, Walker KZ, Barrington V, Andrianopoulos N

(2010), J Hum Nutr Diet, 23(3), 212-6

The thienopyridine class of antiplatelet drugs

Kaplan Z, Al-Daher S, Salem H

(2010), Med Today, 11(8), LF to check in library

When the hue is blue

Assarian Z, O’Brien TJ, Chamberlain AJ

(2010), Med Today, 11(8), 73-4

The power of polarisation

Pan Y, Cowell L, Chamberlain AJ

(2010), Med Today, 11(3), 60-61

Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure

Handolias D, Salemi R, Murray W, Tan A, Liu W, Viros A, Dobrovic A, Kelly J, McArthur GA

(2010), Pigment Cell Melanoma Res, 23(2), 210-5

522 523 524 525 526